This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Doweiko, J. P. Articles by Bistrian, B. R. Search for Related Content PubMed PubMed Citation Articles by Doweiko, J. P. Articles by Bistrian, B. R. Social Bookmarking                         What's this?

The Effect of Glycosylated Albumin on Platelet Aggregation

Division of Infectious Disease and Division of Hematology/Oncology, New England Deaconess Hospital, Harvard Medical School, Boston, Massachusetts

Bruce R. Bistrian, MD, PHD

Division of Nutritional Medicine, Department of Medicine, New England Deaconess Hospital, Harvard Medical School, Boston, Massachusetts

Background: Albumin has a role in the complicated process of platelet aggregation. Although it is known that quantitative changes in plasma albumin alter platelet aggregation, less is known about the interaction between qualitative changes in plasma albumin and platelets. One common qualitative change in plasma albumin is nonenzymatic glycosylation, which occurs during states of prolonged hyperglycemia. Methods: Albumin was selectively removed from normal plasma by means of an affinity column. Glycosylated albumin was added to this albumin-poor plasma, and it was used to study platelet aggregation induced by low concentrations of arachidonic acid. Platelet aggregation was determined by light transmittance. Results: As the concentration of glucose in which albumin was incubated was increased, there was progressive augmentation of platelet aggregation. At a plasma glucose of 150 mg/dL, average light transmittance was 9.4%, and at 200 mg/dL, it was 24.6%. These values were significantly different at a p value < .01. At glucose levels of 300 mg/dL and 400 mg/dL, mean light transmittance was 40.6% and 74.4%, respectively, and these values were significantly different with p values of < .01. Conclusions: Platelet aggregation in response to a relatively low concentration of arachidonic acid is enhanced in the presence of albumin that has been incubated in a medium containing levels of glucose that are higher than would be seen in normal patients but are consistent with those seen in diabetics with less than optimal control. This augmentation of platelet aggregation is statistically significant. (Journal of Parenteral and Enteral Nutrition 18:516-520, 1994)

Journal of Parenteral and Enteral Nutrition, Vol. 18, No. 6, 516-520 (1994)
DOI: 10.1177/0148607194018006516


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L. R. Lester, C. M. Crill, and E. B. Hak Should adding albumin to parenteral nutrient solutions be considered an unsafe practice? Am. J. Health Syst. Pharm., September 1, 2006; 63(17): 1656 - 1661. [Abstract] [Full Text] [PDF]

				P. R. Schloerb Glucose in Parenteral Nutrition: A Survey of US Medical Centers JPEN J Parenter Enteral Nutr, November 1, 2004; 28(6): 447 - 452. [Abstract] [Full Text] [PDF]

				P. R. Schloerb Electronic Parenteral and Enteral Nutrition JPEN J Parenter Enteral Nutr, January 1, 2000; 24(1): 23 - 29. [Abstract] [PDF]

				P. R. Schloerb and J. F. Henning Patterns and Problems of Adult Total Parenteral Nutrition Use in US Academic Medical Centers Arch Surg, January 1, 1998; 133(1): 7 - 12. [Abstract] [Full Text] [PDF]